Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model
Polish Journal of Veterinary Sciences · 15.06.2026 · 29 (2)
DOI: 10.24425/pjvs.2026.1273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polish Journal of Veterinary Sciences, online erschienen am 15.06.2026. Verfasst von W H Mahallawi. Beteiligte Einrichtung: Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taibah University, Prince Nayef bin Abdulaziz Road, 42353, Madinah, Sau…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, Influenza A Virus, H1N1 Subtype, Antigens, Viral. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The development of mucosal vaccines is crucial for controlling the transmission of respiratory viruses such as SARS-CoV-2 and influenza at their point of entry. This study aimed to validate a human tonsil-derived in vitro model for screening antigen formulation candidates and to evaluate the immunogenicity of a novel bivalent formulation. Mononuclear cells (MNCs) isolated from human palatine tonsils (n=20) were stimulated with full-length SARS-CoV-2 spike (S) glycoprotein, influenza A (H1N1) hemagglutinin (HA), or a combination of both (bivalent) at a concentration of 20 μg/mL. After a 10-day culture, antigen-specific IgG, IgM, and IgA antibody levels were quantified by enzyme-linked immunosorbent assay (ELISA). Stimulation with individual antigens elicited robust polyisotypic antibody responses. The S protein induced significant fold-increases over unstimulated controls for IgG (8.23, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory Sciences Department, College of Applied Medical Sciences, Taibah University, Prince Nayef bin Abdulaziz Road, 42353, Madinah, Saudi Arabia; Health and Life Research Center, Taibah University, Prince…
Zitieren
APA
Mahallawi, W. H. (2026). Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model. Polish Journal of Veterinary Sciences, 29(2). https://doi.org/10.24425/pjvs.2026.1273
Vancouver
Mahallawi WH. Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model. Polish Journal of Veterinary Sciences. 2026;29(2). doi:10.24425/pjvs.2026.1273
BibTeX
@article{Mahallawi2026,
author = {Mahallawi, W H},
title = {Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model},
journal = {Polish Journal of Veterinary Sciences},
year = {2026},
volume = {29},
number = {2},
doi = {10.24425/pjvs.2026.1273}
}
EUVIMED